Gapping up
In reaction to strong earnings/guidance: BWP +3.7%, GOLD +2.2%, CTS+1.5%, WEX +1%, HAS +0.4%
M&A news: APOL +27.3% (to be acquired by a consortium of investors for $9.50/share in cash), OUTR +3.6% ( being targeted by activist investor Engaged Capital, has rebuffed interest from buyout firms, according to Bloomberg), GPRO +2.9% (Barron's profiles view that GoPro (GPRO) might be a possible takeover target)
Select metals/mining stocks trading higher:AUY +4.4%, GG +3.8%, EGO+3.5%, AG +3.1%, SLW +2.7%, ABX +2.2%, RGLD +2%
Other news: GALE +12.7% (announces the USPTO issued a Notice of Allowance for an additional U.S. patent application covering multiple uses of NeuVax), PLAB +6.5% (still checking), SFM +5.1% ( set to join the S&P MidCap 400), SUPN +4.3% (favorable patent count ruling against Allergan (AGN) ), SGMO +0.7% (FDA has cleared the company's investigational new drug application for SB-318)
Analyst comments: KGC +8.3% (upgraded to Outperform from Market Perform at BMO Capital)
In reaction to strong earnings/guidance: BWP +3.7%, GOLD +2.2%, CTS+1.5%, WEX +1%, HAS +0.4%
M&A news: APOL +27.3% (to be acquired by a consortium of investors for $9.50/share in cash), OUTR +3.6% ( being targeted by activist investor Engaged Capital, has rebuffed interest from buyout firms, according to Bloomberg), GPRO +2.9% (Barron's profiles view that GoPro (GPRO) might be a possible takeover target)
Select metals/mining stocks trading higher:AUY +4.4%, GG +3.8%, EGO+3.5%, AG +3.1%, SLW +2.7%, ABX +2.2%, RGLD +2%
Other news: GALE +12.7% (announces the USPTO issued a Notice of Allowance for an additional U.S. patent application covering multiple uses of NeuVax), PLAB +6.5% (still checking), SFM +5.1% ( set to join the S&P MidCap 400), SUPN +4.3% (favorable patent count ruling against Allergan (AGN) ), SGMO +0.7% (FDA has cleared the company's investigational new drug application for SB-318)
Analyst comments: KGC +8.3% (upgraded to Outperform from Market Perform at BMO Capital)